purpose retrospectively analyze long term results treatment patterns failure patients chordoma sacrum base skull mobile spine treated predominantly postoperative photon irradiation materials methods adult patients chordoma sacrum NUMBER base skull NUMBER mobile spine NUMBER seen fortyfour referred post operatively overt disease NUMBER irradiated conventionally fractionated radiation median dose NUMBER fractions5 weeks range gy received hyperfractionation protocol NUMBER gy NUMBER hourly NUMBER times day median NUMBER fractions14 days sacral patients treated hypofractionation protocol cases skull base tumours referred proton therapy endpoints measured survival diagnosis objective response rate symptomatic response rate clinical radiological survival radiotherapy results median survival NUMBER months range month diagnosis difference clival presentations complete partial responses identified NUMBER assessable patients subjective response recorded NUMBER pain NUMBER neurological signs symptoms median time progression overt disease NUMBER months range months survival advantage patients receiving radiation doses NUMBER gy median NUMBER gy compared doses NUMBER gy median NUMBER gy difference conventional hyperfractionation regimens respect degree duration symptomatic response survival fourteen patients progressed irradiation retreated surgery NUMBER irradiation NUMBER modalities NUMBER median survival retreatment NUMBER months symptomatic responses seen reirradiation failure relatively low dose initial therapy NUMBER dead disease seven alive disease thirtyeight local disease persistence sole site failure developed distant metastases initially subsequently discussion overt residual chordoma rarely cured conventional external beam irradiation treatment does provide useful prolonged palliation pain patients chordoma disease low metastatic potential better local control improve survival complete resection rates improved patients sacral disease using planned excisions centres experienced treating rare disease radiation therapy prove successful controlling microscopic disease considered postoperative adjuvant macroscopically complete resection patients skull base disease resected centres specializing surgery complete excision unlikely patients obtain local control conventional photon irradiation suitable patients considered irradiation stereotactic photon particle beam therapy patients progress irradiation limited symptomatic benefit retreatment surgery reirradiation limited treating complications NUMBER NUMBER NUMBER NUMBER progression free NUMBER NUMBER non clival NUMBER NUMBER progression free follow disease free pre life threatening gy NUMBER gy NUMBER NUMBER NUMBER NUMBER NUMBER